1. P04.05 Targeted Gene-Expression analysis during malignant transformation in primary and secondary malignant meningioma. (9th September 2021) Authors: Maier, A D; Meddis, A; Haslund-Vinding, J; Mirian, C; Areskeviciute, A; Nguyen, P; Westergaard, C; Melchior, L C; Munch, T N; Skjøth-Rasmussen, J; Poulsgaard, L; Ziebell, M; Bartek Jr, J; Broholm, H; Poulsen, F R; Gerds, T A; Scheie, D; Mathiesen, T Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PL02.3.A Survival and T-cell tumor reactivity in patients treated with nivolumab and bevacizumab for recurrent glioblastoma in the clinical trial CA209-9UP. (5th September 2022) Authors: Maarup, S; Skadborg, S; Draghi, A; Borch, A; Hasselbalch, B; Yde, C; Svane, I; Hadrup, S; Christensen, I; Law, I; Skjoeth-Rasmussen, J; Scheie, D; Skovgaard Poulsen, H; Lassen, U Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗